Fundz

Explorna Therapeutics Receives Funding To Advance Its Novel Mrna Technology

PRIVATEDec 07, 2022

Round Type

Funding Round

WarsawBiotechnologyHealth CareTherapeuticsPharmaceutical

Description

ExPLoRNA Therapeutics, a Polish biotech company revolutionizing mRNA vaccines and therapeutics with unprecedented translational efficiency, received funding from the Bill & Melinda Gates Foundation to further develop its unique mRNA technology. ExPLoRNA specializes in novel cap analogs, the starting part of mRNA that is crucial for enabling successful production of the encoded protein. ExPLoRNA's technology increases protein production beyond scale observable so far with other standard cap analogs.

Quick answer

ExPLoRNA Therapeutics raised an undisclosed amount in a Funding Round round, dated December 7, 2022. ExPLoRNA Therapeutics is based in Warsaw, Masovian Voivodeship, Poland.

How much did ExPLoRNA Therapeutics raise?
ExPLoRNA Therapeutics raised an undisclosed amount in a Funding Round round on December 7, 2022.
What does ExPLoRNA Therapeutics do?
Our mission is to deliver mRNA technology innovations to revolutionize future therapies and the prevention of many diseases.
Where is ExPLoRNA Therapeutics based and how big is it?
ExPLoRNA Therapeutics is based in Warsaw, Masovian Voivodeship, Poland.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as ExPLoRNA Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Liquidia raised an undisclosed amount (Debt Financing) on January 9, 2023.
  • HighTide Therapeutics raised $107M (Series C) on January 5, 2023.
  • Madrigal Pharmaceuticals raised $300M (Funding Round) on December 21, 2022.
  • Parabilis Medicines raised $178M (Series D) on November 21, 2022.
  • Parabilis Medicines raised $178M on November 17, 2022.
  • Os Therapies raised $2M on November 16, 2022.

Who to call at ExPLoRNA Therapeutics, and when

A new round usually means ExPLoRNA Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ExPLoRNA Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ExPLoRNA Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ExPLoRNA Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ExPLoRNA Therapeutics

Location

Warsaw, Masovian Voivodeship, Poland

About

Our mission is to deliver mRNA technology innovations to revolutionize future therapies and the prevention of many diseases. We invent, develop, manufacture and apply our solutions for the benefit of pharmaceutical partners, and to improve people’s lives. With passion, ExploRNA Therapeutics develops ground-breaking innovations of mRNA as a therapeutic platform, applies those solutions in unique therapeutic programs, and delivers technology, therapeutic platform, and therapies to pharmaceutical partners. The future of healthcare belongs to therapeutic mRNA

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ExPLoRNA Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for ExPLoRNA Therapeutics's next move

See what Strategic adds

ExPLoRNA Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.